ICZOOM Receives Nasdaq Deficiency Notice for Late Interim Filing
IZM sits 20% above its 52-week low of $0.263 on light trading volume (0.2× avg).
Summary
ICZOOM received a Nasdaq deficiency letter for not filing its interim financials for the period ended December 31, 2025. The company has 60 days to submit a compliance plan or face delisting proceedings.
Key Events · Legal and Risk Events · IZM
-
Nasdaq Deficiency Notice Received
On July 14, 2026, Nasdaq notified ICZOOM it is not in compliance with Listing Rule 5250(c)(2) due to the late filing of its interim financials for the six months ended December 31, 2025.
-
Compliance Plan Deadline
The company has until September 14, 2026 (60 days) to submit a plan to regain compliance. If accepted, Nasdaq may grant an extension until December 28, 2026 to file the overdue report.
-
Delisting Risk
If the plan is not accepted or the company fails to file by the extended deadline, Nasdaq will initiate delisting proceedings, though the company can appeal to a Hearings Panel.
-
Non-Compliance Indicator
Nasdaq will disseminate a non-compliance indicator through its market data systems starting five business days after the notice, potentially impacting trading and investor perception.
Analysis · IZM · Trade & Services
A Nasdaq listing deficiency notice has been triggered by ICZOOM's failure to file its interim financials for the six months ended December 31, 2025. The company now has until September 14, 2026 to submit a compliance plan. If accepted, it could get until December 28, 2026 to file. Failure to regain compliance risks delisting — a severe outcome for a micro-cap stock already trading near $0.32. The late filing raises concerns about internal controls and financial reporting capabilities, especially given recent board changes and a postponed shareholder meeting.
At the time of this filing, IZM was trading at $0.32 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $3.6M. The 52-week trading range was $0.26 to $2.74. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.